Welcome!

News Feed Item

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

LONDON, March 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022


EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022

Summary

Overweight and obesity are characterized by abnormal or excessive fat accumulation in the body, which can increase the likelihood of developing type 2 diabetes and cardiovascular diseases. Obesity is an escalating public health problem with an increasing worldwide prevalence and has become a well-known threat to public health. As obesity is a complex condition associated with a wide range of lifestyle, genetic, social, cultural, and environmental factors, its prevalence may vary across countries, depending on the variations in these contributing factors.

GlobalData's epidemiological analysis forecasts that prevalent cases of overweight in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada) will increase from 250.05 million in 2012 to 271.86 million cases in 2022 at an annual growth rate (AGR) of 0.86%. Approximately 57% of the 250.05 million prevalent cases of overweight adults in the 9MM in 2012 were in men. GlobalData epidemiologists forecast that there were 167.39 million prevalent cases of obesity in the 9MM in 2012, which will increase to 213.34 million cases in 2022, increasing at an AGR of 2.75%. Approximately 52% of the 167.39 million prevalent cases of obese adults in the 9MM in 2012 were in women.

According to GlobalData's forecast, the prevalent cases of both overweight and obesity will increase dramatically over the next decade, with the number of obese adults increasing by an alarming 27.50%. Overweight and obesity have reached pandemic proportions; however, GlobalData epidemiologists believe that with the alarming increase in the prevalence of both overweight and obesity, the morbidity and mortality associated with the disease will continue to increase dramatically as well.

Scope

- The Overweight and Obesity EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of overweight and obesity in the 9MM (US, France, Germany, Italy, Spain, UK, Japan, Brazil, and Canada). It includes a 10-year epidemiology forecast of the prevalent cases of overweight, obesity, obesity class I, obesity class II, and obesity class III segmented by sex and age. In addition, the report includes a 10-year forecast of the prevalent cases of obesity-associated comorbidities, including diagnosed diabetes, diagnosed hypertension, and dyslipidemia, among adults with overweight/obesity in some of these markets.
- The overweight and obesity epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 9MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global overweight and obesity market.
- Quantify patient populations in the global overweight and obesity market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for overweight and obesity therapeutics in each of the markets covered.
- Identify the number of obesity class I, obesity class II, and obesity class III prevalent cases.
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Epidemiology 12

3.1 Disease Overview 12
3.2 Risk Factors and Comorbidities 13
3.2.1 Family history is a strong predictor of obesity 13
3.2.2 Physical inactivity is an independent predictor of obesity 14
3.2.3 Excessive caloric intake doubles the risk for obesity 15
3.2.4 Hypertension is as high as 42% in obese adults 16
3.2.5 Dyslipidemia and type 2 diabetes are common comorbidities in obese patients 17
3.3 Global Trends 19
3.3.1 US 20
3.3.2 5EU 22
3.3.3 Japan 28
3.3.4 Brazil 29
3.3.5 Canada 31
3.4 Forecast Methodology 32
3.4.1 Sources Used 39
3.4.2 Forecast Assumptions and Methods: Prevalent Cases of Overweight, Obesity, Obesity by Class, and Comorbidities 46
3.4.3 Sources Not Used 63
3.5 Epidemiology Forecast of Overweight (2012–2022) 63
3.5.1 Prevalent Cases of Overweight 63
3.5.2 Age-Specific Prevalent Cases of Overweight 65
3.5.3 Sex-Specific Prevalent Cases of Overweight 67
3.5.4 Age-Standardized Prevalence of Overweight 70
3.6 Epidemiology Forecast of Obesity (2012–2022) 71
3.6.1 Prevalent Cases of Obesity 71
3.6.2 Age-Specific Prevalent Cases of Obesity 73

3.6.3 Sex-Specific Prevalent Cases of Obesity 75
3.6.4 Age-Standardized Prevalence of Obesity 76
3.7 Epidemiology Forecast of Obesity Class I (2012–2022) 77
3.7.1 Prevalent Cases of Obesity Class I 77
3.7.2 Age-Specific Prevalent Cases of Obesity Class I 79
3.7.3 Sex-Specific Prevalent Cases of Obesity Class I 81
3.7.4 Age-Standardized Prevalence of Obesity Class I 83
3.8 Epidemiology Forecast of Obesity Class II (2012–2022) 85
3.8.1 Prevalent Cases of Obesity Class II 85
3.8.2 Age-Specific Prevalent Cases of Obesity Class II 87
3.8.3 Sex-Specific Prevalent Cases of Obesity Class II 89
3.8.4 Age-Standardized Prevalence of Obesity Class II 91
3.9 Epidemiology Forecast of Obesity Class III (2012–2022) 93
3.9.1 Prevalent Cases of Obesity Class III 93
3.9.2 Age-Specific Prevalent Cases of Obesity Class III 95
3.9.3 Sex-Specific Prevalent Cases of Obesity Class III 97
3.9.4 Age-Standardized Prevalence of Obesity Class III 99
3.10 Epidemiology Forecast of Comorbidities among Adults with Overweight/Obesity (2012 and 2022) 101
3.10.1 Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity 101
3.10.2 Prevalent Cases of Diagnosed Hypertension in Adults with Overweight/Obesity 104
3.10.3 Prevalent Cases of Dyslipidemia among Adults with Overweight/Obesity 106
3.11 Discussion 109
3.11.1 Conclusions on Epidemiological Trends 109
3.11.2 Limitations of the Analysis 110

3.11.3 Strengths of the Analysis 111
4 Appendix 112
4.1 Bibliography 112
4.2 About the Authors 118
4.2.1 Epidemiologists 118
4.2.2 Reviewers 118
4.2.3 Global Director of Epidemiology and Health Policy 119
4.2.4 Global Head of Healthcare 120
4.3 About GlobalData 121
4.4 About EpiCast 121
4.5 Disclaimer 121

1.1 List of Tables

Table 1: The WHO Classification System of Adult Overweight and Obesity According to BMI 12
Table 2: Risk Factors and Comorbidities of Obesity 13
Table 3: 9MM, Age-Adjusted and Crude Prevalence (%) of Obesity, by Sex, Ages ?20 Years, 2008 20
Table 4: JASSO and WHO Classifications of Obesity 28
Table 5: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Overweight 33
Table 6: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity 34
Table 7: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Obesity Class I, Class II, and Class III 36
Table 8: Sources of Epidemiological Data Used for Forecasting the Prevalent Cases of Comorbidities in Overweight/Obese 38
Table 9: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 64
Table 10: 9MM, Prevalent Cases of Overweight, By Age, Both Sexes, N (Millions), Row (%), 2012 66
Table 11: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 68

Table 12: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 72
Table 13: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), Row (%), 2012 74
Table 14: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), Row (%), 2012 75
Table 15: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 78
Table 16: 9MM, Prevalent Cases of Obesity Class I, by Age, Both Sexes, N (Millions), Row (%), 2012 80
Table 17: 9MM, Prevalent Cases of Obesity Class I, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 82
Table 18: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 86

Table 19: 9MM, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), Row (%), 2012 88
Table 20: 9MM, Prevalent Cases of Obesity Class II, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 90
Table 21: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 94
Table 22: 9MM, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), Row (%), 2012 96
Table 23: 9MM, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), Row (%), 2012 98
Table 24: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 102
Table 25: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 105
Table 26: 4MM, Prevalent Cases of Dyslipidemia* among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 and 2022 107

1.2 List of Figures

Figure 1: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Men, 1960–2010 21
Figure 2: US, Overweight and Obesity Age-Adjusted Prevalence (%), Ages 20–74 Years, Women, 1960–2010 21
Figure 3: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Men, 1997–2006 23
Figure 4: France, Overweight and Obesity Prevalence (%), Ages ?15 Years, Women, 1997–2006 23
Figure 5: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 6: Italy, Overweight and Obesity Prevalence (%), Ages ?18, Men, 1983–2010 25
Figure 7: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Men, 1993–2011 27
Figure 8: UK, Overweight and Obesity Prevalence (%), Ages ?16 Years, Women, 1993–2011 27
Figure 9: Japan, Obesity Prevalence (%), Ages ?20 Years, By Sex, 1976–2006 29
Figure 10: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Men, 1975–2003 30
Figure 11: Brazil, Overweight and Obesity Prevalence (%), Ages ?20 Years, Women, 1975–2003 30
Figure 12: Canada, Obesity Prevalence (%), Ages ?18 Years, Both Sexes, 1978–2008 32
Figure 13: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 65
Figure 14: 9MM, Prevalent Cases of Overweight, by Age, Both Sexes, N (Millions), 2012 67
Figure 15: 9MM, Prevalent Cases of Overweight, Ages ?18 Years, by Sex, N (Millions), 2012 69
Figure 16: 9MM, Overweight Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 71
Figure 17: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 73

Figure 18: 9MM, Prevalent Cases of Obesity, By Age, Both Sexes, N (Millions), 2012 74
Figure 19: 9MM, Prevalent Cases of Obesity, Ages ?18 Years, by Sex, N (Millions), 2012 76
Figure 20: 9MM, Obesity Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 77
Figure 21: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 79
Figure 22: 9MM*, Prevalent Cases of Obesity Class I, By Age, Both Sexes, N (Millions), 2012 81
Figure 23: 9MM*, Prevalent Cases of Obesity Class I, Ages ?18 Years, by Sex, N (Millions), 2012 83
Figure 24: 9MM*, Obesity Class I Age-Standardized Prevalence (%), Ages ?18 Years, by Sex, 2012 84
Figure 25: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 87
Figure 26: 9MM*, Prevalent Cases of Obesity Class II, By Age, Both Sexes, N (Millions), 2012 89
Figure 27: 9MM*, Prevalent Cases of Obesity Class II, Ages ?18 Years, by Sex, N (Millions), 2012 91
Figure 28: 9MM*, Age-Standardized Prevalence (%) of Obesity Class II, Ages ?18 Years, By Sex, 2012 92
Figure 29: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, Both Sexes, N (Millions), 2012–2022 95
Figure 30: 9MM*, Prevalent Cases of Obesity Class III, By Age, Both Sexes, N (Millions), 2012 97
Figure 31: 9MM*, Prevalent Cases of Obesity Class III, Ages ?18 Years, By Sex, N (Millions), 2012 99
Figure 32: 9MM*, Obesity Class III Age-Standardized Prevalence (%), Ages ?18 Years, By Sex, 2012 100
Figure 33: 5MM*, Prevalent Cases of Diagnosed Diabetes among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 103
Figure 34: 6MM*, Prevalent Cases of Diagnosed Hypertension among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 106
Figure 35: 4MM*, Prevalent Cases of Dyslipidemia** among Adults with Overweight/Obesity, Both Sexes, N (Millions), 2012 108

Read the full report:
EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/diseases/epicast_report_overweight_obesity_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com  
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
FinTechs use the cloud to operate at the speed and scale of digital financial activity, but are often hindered by the complexity of managing security and compliance in the cloud. In his session at 20th Cloud Expo, Sesh Murthy, co-founder and CTO of Cloud Raxak, showed how proactive and automated cloud security enables FinTechs to leverage the cloud to achieve their business goals. Through business-driven cloud security, FinTechs can speed time-to-market, diminish risk and costs, maintain continu...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
Any startup has to have a clear go –to-market strategy from the beginning. Similarly, any data science project has to have a go to production strategy from its first days, so it could go beyond proof-of-concept. Machine learning and artificial intelligence in production would result in hundreds of training pipelines and machine learning models that are continuously revised by teams of data scientists and seamlessly connected with web applications for tenants and users.
What sort of WebRTC based applications can we expect to see over the next year and beyond? One way to predict development trends is to see what sorts of applications startups are building. In his session at @ThingsExpo, Arin Sime, founder of WebRTC.ventures, discussed the current and likely future trends in WebRTC application development based on real requests for custom applications from real customers, as well as other public sources of information.
In his session at 20th Cloud Expo, Mike Johnston, an infrastructure engineer at Supergiant.io, discussed how to use Kubernetes to set up a SaaS infrastructure for your business. Mike Johnston is an infrastructure engineer at Supergiant.io with over 12 years of experience designing, deploying, and maintaining server and workstation infrastructure at all scales. He has experience with brick and mortar data centers as well as cloud providers like Digital Ocean, Amazon Web Services, and Rackspace. H...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
"The Striim platform is a full end-to-end streaming integration and analytics platform that is middleware that covers a lot of different use cases," explained Steve Wilkes, Founder and CTO at Striim, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Calligo, an innovative cloud service provider offering mid-sized companies the highest levels of data privacy and security, has been named "Bronze Sponsor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Calligo offers unparalleled application performance guarantees, commercial flexibility and a personalised support service from its globally located cloud plat...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
SYS-CON Events announced today that Datera, that offers a radically new data management architecture, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera is transforming the traditional datacenter model through modern cloud simplicity. The technology industry is at another major inflection point. The rise of mobile, the Internet of Things, data storage and Big...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, will examine the regulations and provide insight on how it affects technology, challenges the established rules and will usher in new levels of diligence...
In his session at @ThingsExpo, Sudarshan Krishnamurthi, a Senior Manager, Business Strategy, at Cisco Systems, discussed how IT and operational technology (OT) work together, as opposed to being in separate siloes as once was traditional. Attendees learned how to fully leverage the power of IoT in their organization by bringing the two sides together and bridging the communication gap. He also looked at what good leadership must entail in order to accomplish this, and how IT managers can be the ...
DX World EXPO, LLC., a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.